Depakote and Depakote ER, broadens the indication of Depakote ER, omits indication statement, Please see full Indications on
Depakote is indicated for treatment of manic episodes associated with bipolar disorder. Depakote ER Extended-Release Tablets are indicated for acute treatment
DEPAKOTE and DEPAKOTE ER are indicated for prophylaxis of migraine headaches. There is no evidence that DEPAKOTE ER or DEPAKOTE is useful in the acute treatment
Depakote is indicated for treatment of manic episodes associated with bipolar disorder. Depakote ER Extended-Release Tablets are indicated for acute treatment
Depakene, Depakote, Depakote ER, Depakote Sprinkle, Stavzor. Why is Valproic Acid Prescribed? (Indications). This medication is an anticonvulsant, prescribed
Depakote is indicated for treatment of manic episodes associated with bipolar disorder. Depakote ER Extended-Release Tablets are indicated for acute treatment
Depakote; Depakote ER; Depakote Sprinkle; Epival Canadian Trade name Indications Action Pharmacokinetics Contraindication / Precautions Adverse
Pronunciation. (val PROE ik AS id dah RIV ah tives). Brand Names: U.S. Depakote; Depakote ER; Depakote Sprinkles. Indications. Use: Labeled Indications.
Depakote – valproic acid/divalproex (View the FDA label) INDICATION AND USES: Depakote is an anti-epileptic drug indicated for:
Comments